Results 21 to 30 of about 87,116 (304)

Paraneoplastic hypoglycaemia secondary to IGF-2 secretion from a metastatic gastrointestinal stromal tumour [PDF]

open access: yes, 2020
We report the case of a 79-year-old male with previous history of non-Hodgkin's lymphoma in remission, who presented acutely to the Accident and Emergency department with recurrent episodes of hypoglycaemia.
Dimitriadis, Georgios K.   +9 more
core   +1 more source

Local resection of gastrointestinal stromal tumor of the second part of duodenum

open access: yesJournal of Nepal Medical Association, 2010
Gastrointestinal stromal tumors are relatively rare in the duodenum, representing 2-4% of Gastrointestinal stromal tumors of the gastrointestinal tract.
R Kansakar, S Adhikari
doaj   +1 more source

Hedgehog pathway dysregulation contributes to the pathogenesis of human gastrointestinal stromal tumors via GLI-mediated activation of KIT expression. [PDF]

open access: yes, 2016
Gastrointestinal stromal tumors (GIST) arise within the interstitial cell of Cajal (ICC) lineage due to activating KIT/PDGFRA mutations. Both ICC and GIST possess primary cilia (PC), which coordinate PDGFRA and Hedgehog signaling, regulators of ...
Bardsley, Michael R   +18 more
core   +2 more sources

Role of novel marker discovered on gastrointestinal stromal tumor 1 in evaluation of gastrointestinal stromal tumors

open access: yesIndian Journal of Medical and Paediatric Oncology, 2019
Background: Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal tumors arising from myenteric ganglion cells, termed interstitial cells of Cajal. GISTs occur predominantly between 40 and 60 years of age.
Farhat Abbas   +5 more
doaj   +1 more source

Gastric volvulus associated with shrinkage of a gastrointestinal stromal tumor by neoadjuvant imatinib: a case report

open access: yesJournal of Medical Case Reports, 2023
Background During neoadjuvant chemotherapy for giant gastrointestinal stromal tumors, changes in gastrointestinal stromal tumor size are rarely associated with events such as perforation and bleeding that require emergency surgery.
Yoichi Sugiyama   +5 more
doaj   +1 more source

Gastrointestinal carcinoma and sarcoma surgery [PDF]

open access: yes, 2019
A number of advances in both earlier diagnostic imaging and better treatment options for patients with intra-abdominal malignancies have occurred. Frequently such newer therapies rely on the integration of established surgical and radiation approaches ...
Koniaris, Leonidas G.
core   +1 more source

Contrast Enhanced Endoscopic Ultrasound Imaging for Gastrointestinal Subepithelial Tumors [PDF]

open access: yesClinical Endoscopy, 2019
Subepithelial tumors are divided into benign subepithelial and potentially malignant gastrointestinal stromal tumors. It is difficult to distinguish between these tumor types.
Takashi Tamura, Masayuki Kitano
doaj   +1 more source

Contribution of galectin-1, a glycan-binding protein, to gastrointestinal tumor progression [PDF]

open access: yes, 2017
Gastrointestinal cancer is a group of tumors that affect multiple sites of the digestive system, including the stomach, liver, colon and pancreas. These cancers are very aggressive and rapidly metastasize, thus identifying effective targets is crucial ...
Bacigalupo, Maria Lorena   +2 more
core   +1 more source

New Risk Classification of Gastrointestinal Stromal Tumors Based on Tumor Size and Three Indices Derived from Rapid Flow Cytometry of Fine-Needle Aspiration Specimens

open access: yesTokyo Women's Medical University Journal, 2023
Background: Biopsies of suspected gastrointestinal stromal tumors in submucosal locations, which were once a challenge, are now easily performed with endoscopic ultrasound-guided fine-needle aspiration.
Kiyoaki Taniguchi   +9 more
doaj   +1 more source

A taxonomy of epithelial human cancer and their metastases [PDF]

open access: yes, 2009
Background: Microarray technology has allowed to molecularly characterize many different cancer sites. This technology has the potential to individualize therapy and to discover new drug targets.
Olivier Gevaert   +76 more
core   +3 more sources

Home - About - Disclaimer - Privacy